Hypoxia as a factor for 67Ga accumulation in tumour cells. 2004

S Kinuya, and X F Li, and K Yokoyama, and H Mori, and K Shiba, and N Watanabe, and N Shuke, and H Bunko, and T Michigishi, and N Tonami
Department of Biotracer Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan. kinuya@med.kanazawa-u.ac.jp

Recent reports have demonstrated that hypoxia induces the up-regulation of transferrin receptor expression in tumour cells. Tumour cells take up 67Ga in the form of a 67Ga-transferrin complex via transferrin receptors. As a result, we attempted to determine the influence of hypoxic conditions on 67Ga uptake in tumour cells. B16 melanoma cells and LS180 colon cancer cells were incubated in 95% air/5% CO2 or 95% N2/5% CO2 for 1 h at 37 degrees C. Cellular uptake of 67Ga citrate was subsequently determined at 20, 40, 60 and 90 min. Uptake of the 67Ga-transferrin complex pre-chelated in vitro was similarly assessed. The effect of hypoxia on 67Ga binding to serum proteins was also investigated. Both B16 and LS180 cells displayed increased cellular uptake of 67Ga citrate in N2 gas in comparison to that in air (P < 0.0001). Hypoxia more prominently influenced cellular uptake of Ga-transferrin relative to that of 67Ga citrate (P < 0.0001). Hypoxia did not affect the percentages of 67Ga radioactivity bound to protein in medium supplemented with fetal calf serum, indicating that the results were not caused by the alteration of 67Ga-transferrin formation. These findings suggest the role of tissue hypoxia with respect to accumulation of 67Ga in tumours, which is likely mediated by transferrin receptors.

UI MeSH Term Description Entries
D008546 Melanoma, Experimental Experimentally induced tumor that produces MELANIN in animals to provide a model for studying human MELANOMA. B16 Melanoma,Melanoma, B16,Melanoma, Cloudman S91,Melanoma, Harding-Passey,Experimental Melanoma,Experimental Melanomas,Harding Passey Melanoma,Melanomas, Experimental,B16 Melanomas,Cloudman S91 Melanoma,Harding-Passey Melanoma,Melanoma, Harding Passey,Melanomas, B16,S91 Melanoma, Cloudman
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D002951 Citrates Derivatives of CITRIC ACID.
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D005708 Gallium A rare, metallic element designated by the symbol, Ga, atomic number 31, and atomic weight 69.72.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014168 Transferrin An iron-binding beta1-globulin that is synthesized in the LIVER and secreted into the blood. It plays a central role in the transport of IRON throughout the circulation. A variety of transferrin isoforms exist in humans, including some that are considered markers for specific disease states. Siderophilin,Isotransferrin,Monoferric Transferrins,Serotransferrin,Transferrin B,Transferrin C,beta 2-Transferrin,beta-1 Metal-Binding Globulin,tau-Transferrin,Globulin, beta-1 Metal-Binding,Metal-Binding Globulin, beta-1,Transferrins, Monoferric,beta 1 Metal Binding Globulin,beta 2 Transferrin,tau Transferrin

Related Publications

S Kinuya, and X F Li, and K Yokoyama, and H Mori, and K Shiba, and N Watanabe, and N Shuke, and H Bunko, and T Michigishi, and N Tonami
June 1989, Nuklearmedizin. Nuclear medicine,
S Kinuya, and X F Li, and K Yokoyama, and H Mori, and K Shiba, and N Watanabe, and N Shuke, and H Bunko, and T Michigishi, and N Tonami
December 2003, European journal of nuclear medicine and molecular imaging,
S Kinuya, and X F Li, and K Yokoyama, and H Mori, and K Shiba, and N Watanabe, and N Shuke, and H Bunko, and T Michigishi, and N Tonami
January 2002, Nature reviews. Cancer,
S Kinuya, and X F Li, and K Yokoyama, and H Mori, and K Shiba, and N Watanabe, and N Shuke, and H Bunko, and T Michigishi, and N Tonami
January 2008, International journal of oncology,
S Kinuya, and X F Li, and K Yokoyama, and H Mori, and K Shiba, and N Watanabe, and N Shuke, and H Bunko, and T Michigishi, and N Tonami
July 1974, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
S Kinuya, and X F Li, and K Yokoyama, and H Mori, and K Shiba, and N Watanabe, and N Shuke, and H Bunko, and T Michigishi, and N Tonami
January 1984, Seminars in nuclear medicine,
S Kinuya, and X F Li, and K Yokoyama, and H Mori, and K Shiba, and N Watanabe, and N Shuke, and H Bunko, and T Michigishi, and N Tonami
November 1987, Radioisotopes,
S Kinuya, and X F Li, and K Yokoyama, and H Mori, and K Shiba, and N Watanabe, and N Shuke, and H Bunko, and T Michigishi, and N Tonami
April 2004, World journal of gastroenterology,
S Kinuya, and X F Li, and K Yokoyama, and H Mori, and K Shiba, and N Watanabe, and N Shuke, and H Bunko, and T Michigishi, and N Tonami
May 2005, Annals of the New York Academy of Sciences,
S Kinuya, and X F Li, and K Yokoyama, and H Mori, and K Shiba, and N Watanabe, and N Shuke, and H Bunko, and T Michigishi, and N Tonami
November 1935, Canadian Medical Association journal,
Copied contents to your clipboard!